Home/Filings/4/0001179110-20-003675
4//SEC Filing

Grunberg Gregory 4

Accession 0001179110-20-003675

CIK 0001479419other

Filed

Mar 15, 8:00 PM ET

Accepted

Mar 16, 7:59 AM ET

Size

6.9 KB

Accession

0001179110-20-003675

Insider Transaction Report

Form 4
Period: 2020-03-13
Grunberg Gregory
Director10% Owner
Transactions
  • Purchase

    Common Stock

    2020-03-13$7.89/sh+2,534,854$19,999,9982,534,854 total(indirect: By Longitude Venture Partners IV, L.P.)
Holdings
  • Common Stock

    (indirect: By Longitude Venture Partners II, L.P.)
    2,877,006
Footnotes (2)
  • [F1]Longitude Capital Partners IV, LLC ("LCP IV") is the general partner of Longitude Venture Partners IV, L.P. ("LVP IV") and may be deemed to have voting, investment and dispositive power with respect to such securities. Patrick G. Enright, Juliet Tammenoms Bakker are the managing members of LCP IV. Each of LCP IV, Mr. Enright, Ms. Tammenoms Bakker and the Reporting Person (a member of the Issuer's board of directors) disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.
  • [F2]Longitude Capital Partners II, LLC ("LCP II") is the general partner of Longitude Venture Partners II, L.P. ("LVP II") and may be deemed to have voting, investment and dispositive power with respect to such securities. Patrick G. Enright, Juliet Tammenoms Bakker are the managing members of LCP II. Each of LCP II, Mr. Enright, Ms. Tammenoms Bakker and the Reporting Person (a member of the Issuer's board of directors) disclaim beneficial ownership over such securities except to the extent of their respective pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.

Issuer

Kala Pharmaceuticals, Inc.

CIK 0001479419

Entity typeother

Related Parties

1
  • filerCIK 0001711080

Filing Metadata

Form type
4
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 7:59 AM ET
Size
6.9 KB